Alaunos Therapeutics, Inc. - Common stock (TCRT)

CUSIP: 98973P309

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common stock
Shares outstanding
2,198,384
Total 13F shares
70,134
Share change
-1,074
Total reported value
$102,359
Price per share
$1.47
Number of holders
25
Value change
-$2,277
Number of buys
6
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 98973P309?
CUSIP 98973P309 identifies TCRT - Alaunos Therapeutics, Inc. - Common stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Alaunos Therapeutics, Inc. - Common stock (TCRT) as of Q1 2025

As of 31 Mar 2025, Alaunos Therapeutics, Inc. - Common stock (TCRT) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 70,134 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, Tower Research Capital LLC (TRC), MORGAN STANLEY, OSAIC HOLDINGS, INC., GROUP ONE TRADING LLC, WELLS FARGO & COMPANY/MN, and Steward Partners Investment Advisory, LLC. This page lists 25 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.